Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Berlin

Showing results (171-180 of 221) with videos related to

Pageof 23
Sort By:
European Urology Open Science|January 15, 2026
Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific OutcomesRyan M Putney, Purvish Trivedi, Shivanshu Awasthi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancersAinhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancersAinhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2022
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate CancerRachel M Glicksman, Matthew Ramotar, Ur Metser, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2025
Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical TrialRachel M Glicksman, Jeff Winter, Andrew McPartlin, et al.
Advances in Radiation Oncology|June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain MetastasesMatthew Ramotar, Sierra Barnes, Fabio Moraes, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
NEJM Evidence|February 6, 2024
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate CancerLaila A Gharzai, Ralph Jiang, Elizabeth M Jaworski, et al.
Clinical and Translational Radiation Oncology|January 23, 2025
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international surveyJennifer Le Guévelou, Paul Sargos, Piet Ost, et al.
European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.
Pageof 23

Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
European Urology Open Science|January 15, 2026
Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific OutcomesRyan M Putney, Purvish Trivedi, Shivanshu Awasthi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancersAinhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 31, 2024
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancersAinhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, et al.
International Journal of Radiation Oncology, Biology, Physics|August 28, 2022
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate CancerRachel M Glicksman, Matthew Ramotar, Ur Metser, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2025
Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical TrialRachel M Glicksman, Jeff Winter, Andrew McPartlin, et al.
Advances in Radiation Oncology|June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain MetastasesMatthew Ramotar, Sierra Barnes, Fabio Moraes, et al.
European Urology Oncology|April 2, 2019
Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate CancerHanan Goldberg, Abu-Hijlih Ramiz, Rachel Glicksman, et al.
NEJM Evidence|February 6, 2024
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate CancerLaila A Gharzai, Ralph Jiang, Elizabeth M Jaworski, et al.
Clinical and Translational Radiation Oncology|January 23, 2025
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international surveyJennifer Le Guévelou, Paul Sargos, Piet Ost, et al.
European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.
Pageof 23